Opportunities / VETERANS AFFAIRS, DEPARTMENT OF

6505--Request for Information (RFI) - Specialty Pharmacy – Pharmaceutical Prime Vendor (PPV) 2028

Free · see which open contracts fit your company, with due dates and past-award prices. Sample report →

Notice typeSources Sought
Solicitation #36E79727Q0001
DepartmentVETERANS AFFAIRS, DEPARTMENT OF
Sub-tier / officeVETERANS AFFAIRS, DEPARTMENT OF / NAC PRIME VENDOR (36W797)
NAICS325412 — Pharmaceutical Preparation Manufacturing
PSC6505
Set-asideNone
PostedNov 2, 2026
Response deadlineNov 16, 2026 (2026-11-16T11:00:00-06:00)
Place of performance—
Primary contactKaren Ade · Karen.Ade@va.gov · 708-786-5231
🔔 Get notices like this every morning
New matching SAM.gov notices every morning by Telegram or email. No UEI, no password · 14-day Solo trial, no card.

Registered in SAM.gov? Use your UEI for scores based on your award history.

Description (excerpt)

Department of Veterans Affairs, OALC, EPO AS7 Request for Information (RFI) Specialty Pharmacy Pharmaceutical Prime Vendor (PPV) 2028 Limited Distribution/Closed Distribution Products (CDP) are specialty medications that are generally high-cost, low-volume items for which manufacturers restrict distribution to a small, select network of authorized distributors outside traditional wholesale channels. Specialty Pharmacy dispensed prescriptions, must have a clinical justification or regulatory requirement to restrict dispensing to specialty pharmacies. These products may require additional pharmacy-performed activities such as product-specific registration, safety checks, monitoring, or compliance with manufacturer-mandated dispensing requirements. CDPs may or may not require pass-through delivery depending on the manufacturer's distribution model. The contractor shall ensure that all Federal Supply Schedule (FSS) items requiring specialty distribution including all those not currently/historically included or physically distributed through the Prime Vendor (PPV) are orderable by authorized ordering officers through the pharmaceutical prime vendor ordering platform. When a product requires specialty distribution, the pharmaceutical distributor shall coordinate fulfillment directly with the manufacturer-designated specialty distributor, even in cases where physical possession or shipment bypasses the pharmaceutical prime vendor. The goal is to provide seamless ordering access, accurate invoicing, and visibility into CDP transactions while maintaining compliance with manufacturer restrictions and ensuring timely, compliant delivery to VA facilities. Market Research Questions: Could this be included in the PPV scope? What is the potential impact on pricing, performance, and competition of bringing all FSS CDPs under PPV? Would it be reasonable for any one entity to coordinate the ordering and delivery for all LDD/CDP products that are on and may be added to FSS? Is this scope currently handled within your company? If not, how would your company intend to meet this requirement OR is there another avenue you would recommend? For all currently FSS-listed LDD/CDP products, can your company provide ordering access through the PPV (or a PPV-like) platform, regardless of distribution restrictions? Are there any FSS-listed CDPs your company historically has not been able to access due to manufacturer restrictions? If yes, please specify the nature of the barrier. When n …

View the official notice on SAM.gov →